MX2018002176A - Composiciones para aplicaciones topicas que comprenden peroxido de benzoilo y adapaleno. - Google Patents

Composiciones para aplicaciones topicas que comprenden peroxido de benzoilo y adapaleno.

Info

Publication number
MX2018002176A
MX2018002176A MX2018002176A MX2018002176A MX2018002176A MX 2018002176 A MX2018002176 A MX 2018002176A MX 2018002176 A MX2018002176 A MX 2018002176A MX 2018002176 A MX2018002176 A MX 2018002176A MX 2018002176 A MX2018002176 A MX 2018002176A
Authority
MX
Mexico
Prior art keywords
adapalene
benzoyl peroxide
compositions
topical application
bpo
Prior art date
Application number
MX2018002176A
Other languages
English (en)
Inventor
Toledano Ofer
Seri-Levy Alon
Neimann Karine
Nov Ori
Original Assignee
Sol Gel Tech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sol Gel Tech Ltd filed Critical Sol Gel Tech Ltd
Publication of MX2018002176A publication Critical patent/MX2018002176A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

La invención proporciona composiciones que comprenden como agentes activos peróxido de benzoílo (BPO) y adapaleno, kits y usos de los mismos en métodos para tratar el estado de la superficie de la piel en un sujeto que lo necesite.
MX2018002176A 2015-08-20 2016-08-17 Composiciones para aplicaciones topicas que comprenden peroxido de benzoilo y adapaleno. MX2018002176A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562207452P 2015-08-20 2015-08-20
PCT/IL2016/050895 WO2017029665A1 (en) 2015-08-20 2016-08-17 Compositions for topical application comprising benzoyl peroxide and adapalene

Publications (1)

Publication Number Publication Date
MX2018002176A true MX2018002176A (es) 2018-06-15

Family

ID=58051282

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018002176A MX2018002176A (es) 2015-08-20 2016-08-17 Composiciones para aplicaciones topicas que comprenden peroxido de benzoilo y adapaleno.

Country Status (7)

Country Link
US (1) US20180235924A1 (es)
EP (1) EP3337472A4 (es)
JP (2) JP6526322B2 (es)
CN (1) CN108024980A (es)
CA (1) CA2996022C (es)
MX (1) MX2018002176A (es)
WO (1) WO2017029665A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022542616A (ja) * 2019-08-01 2022-10-05 ボシュ ヘルス アイルランド リミテッド 局所組成物
JP7347511B2 (ja) 2019-08-02 2023-09-20 日本電気株式会社 音声処理装置、音声処理方法、およびプログラム
BR112022023798A2 (pt) * 2020-05-22 2023-01-03 Sol Gel Tech Ltd Microcápsulas estabilizadas, método de sua preparação e usos das mesmas

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4497794A (en) 1980-12-08 1985-02-05 Dermik Laboratories, Inc. Erythromycin/benzoyl peroxide composition for the treatment of acne
US4350681A (en) 1977-10-07 1982-09-21 A.H.C. Pharmacal, Inc. Stabilized benzoyl peroxide compositions
US4361584A (en) 1977-10-07 1982-11-30 A.H.C. Pharmacal, Inc. Composition and method for the treatment of acne
US4235872A (en) 1979-06-04 1980-11-25 E. I. Du Pont De Nemours And Company Microencapsulated methomyl insecticide
US4387107A (en) 1979-07-25 1983-06-07 Dermik Laboratories, Inc. Stable benzoyl peroxide composition
US4670250A (en) 1983-10-21 1987-06-02 Bend Research, Inc. Durable controlled release microcapsules
LU85111A1 (fr) 1983-12-01 1985-09-12 Oreal Composition anti-acnetique a base de peroxyde de benzoyle et d'au moins un filtre solaire
US5086075A (en) 1985-01-24 1992-02-04 Board Of Regents, The University Of Texas System Therapeutic compositions containing benzoyl peroxide
US4690825A (en) 1985-10-04 1987-09-01 Advanced Polymer Systems, Inc. Method for delivering an active ingredient by controlled time release utilizing a novel delivery vehicle which can be prepared by a process utilizing the active ingredient as a porogen
US5446028A (en) 1985-12-12 1995-08-29 Dermik Laboratories, Inc. Anti-acne method and composition
US5955109A (en) 1985-12-18 1999-09-21 Advanced Polymer Systems, Inc. Methods and compositions for topical delivery of retinoic acid
US5145675A (en) 1986-03-31 1992-09-08 Advanced Polymer Systems, Inc. Two step method for preparation of controlled release formulations
US5879716A (en) 1985-12-18 1999-03-09 Advanced Polymer Systems, Inc. Methods and compositions for topical delivery of benzoyl peroxide
EP0248531A3 (en) 1986-05-02 1988-09-28 Southern Research Institute Encapsulated nucleic acids
AT389465B (de) 1987-08-18 1989-12-11 Kwizda Fa F Johann Verfahren zur bildung von mikrokapseln oder mikromatrixkoerpern
FR2628319B1 (fr) 1988-03-09 1990-12-07 Oreal Compositions pharmaceutiques et cosmetiques a base de peroxyde de benzoyle et de sels d'ammonium quaternaires
US4970031A (en) 1988-06-02 1990-11-13 Nok Corporation Process for preparing microcapsules with controlled-release
US5238714A (en) 1990-10-02 1993-08-24 Board Of Regents, The University Of Texas System Efficient microcapsule preparation and method of use
US6117843A (en) 1992-02-18 2000-09-12 Lloyd J. Baroody Compositions for the treatment of acne containing clindamycin and benzoyl peroxide
JPH07506376A (ja) 1992-05-05 1995-07-13 イー・アイ・デユポン・ドウ・ヌムール・アンド・カンパニー マイクロカプセル封入
JP3277342B2 (ja) 1992-09-02 2002-04-22 武田薬品工業株式会社 徐放性マイクロカプセルの製造法
FR2702375B1 (fr) 1993-03-08 1995-05-05 Virbac Laboratoires Microcapsules à libération progressive, leur procédé de préparation et compositions pharmaceutiques ou vétérinaires les contenant.
US5466446A (en) 1994-02-16 1995-11-14 Stiefel Laboratories, Inc. Topical compositions containing bensoyl peroxide and clindamycin and method of use thereof
US5632996A (en) 1995-04-14 1997-05-27 Imaginative Research Associates, Inc. Benzoyl peroxide and benzoate ester containing compositions suitable for contact with skin
US5851538A (en) 1995-12-29 1998-12-22 Advanced Polymer Systems, Inc. Retinoid formulations in porous microspheres for reduced irritation and enhanced stability
US5998392A (en) 1996-04-10 1999-12-07 Gattefosse S.A. Benzoyl peroxide flocculent materials and methods of their preparation
US6337089B1 (en) 1998-02-06 2002-01-08 Seiwa Kasei Company, Limited Microcapsule containing core material and method for producing the same
DE19810803A1 (de) 1998-03-12 1999-09-16 Wacker Chemie Gmbh Verfahren zur Herstellung mikroverkapselter Produkte mit Organopolysiloxanwänden
US6013637A (en) 1998-06-12 2000-01-11 Dermik Laboratories Inc. Anti-acne method and composition
WO2000009652A2 (en) 1998-08-13 2000-02-24 Sol-Gel Technologies Ltd. Method for the preparation of oxide microcapsules loaded with functional molecules and the products obtained thereof
US6238650B1 (en) 1999-05-26 2001-05-29 Sol-Gel Technologies Ltd. Sunscreen composition containing sol-gel microcapsules
US6468509B2 (en) 1998-12-18 2002-10-22 Sol-Gel Technologies Ltd. Sunscreen composition containing sol-gel microcapsules
DE60033279T2 (de) 1999-05-25 2007-11-22 Sol-Gel Technologies Ltd. Ein verfahren zur herstellung von einem lichtstabilen sonnenschutzmittel
US7758888B2 (en) 2000-04-21 2010-07-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
WO2001080823A2 (en) 2000-04-21 2001-11-01 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of tropical active ingredients
GB2377078B (en) 2001-06-27 2003-06-04 Morgan Crucible Co Fuel cell or electrolyser construction
IL161782A0 (en) 2001-11-08 2005-11-20 Sol Gel Technologies Ltd Compositions containing oils havinga specific gravity higher than the specific gravity of water
US7820186B2 (en) 2001-12-21 2010-10-26 Galderma Research & Development Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
FR2833841B1 (fr) * 2001-12-21 2005-07-22 Galderma Res & Dev Gel comprenant au moins un retinoide et du peroxyde de benzoyle
GB0202853D0 (en) 2002-02-07 2002-03-27 Dow Corning Encapsulation process and encapsulated compositions
MXPA05006365A (es) 2002-12-13 2005-08-29 Monsanto Technology Llc Microcapsulas con velocidad de liberacion ajustada con aminas.
WO2004081222A2 (en) 2003-03-14 2004-09-23 Sol-Gel Technologies Ltd. Agent-encapsulating micro- and nanoparticles, methods for preparation of same and products containing same
KR100524820B1 (ko) 2003-06-17 2005-10-31 한국화학연구원 실리카 마이크로캡슐의 제조방법
BRPI0413131A (pt) 2003-07-31 2007-04-10 Sol Gel Technologies Ltd micro-cápsulas carregadas com ingredientes ativos e um método para sua preparação
EP1765071A4 (en) 2004-06-30 2012-12-26 United Phosphorus Ltd DANGER-FREE DISTRIBUTION SYSTEM FOR AGRICULTURALLY ACTIVE MATERIALS
GB2416524A (en) 2004-07-24 2006-02-01 Dow Corning Microcapsules with siloxane walls formed in situ
WO2007015243A2 (en) 2005-08-02 2007-02-08 Sol-Gel Technologies Ltd. Metal oxide coating of water insoluble ingredients
WO2007092312A2 (en) * 2006-02-03 2007-08-16 Stiefel Laboratories, Inc. Topical skin treating compositions
US7629394B2 (en) 2006-02-21 2009-12-08 Appleton Papers Inc. UV curable coating material of encapsulated water dispersed core material
FR2903603B1 (fr) * 2006-07-13 2009-03-20 Galderma Res & Dev S N C Snc Combinaison d'adapalene et de peroxyde de benzole dans le traitement de l'acne
JP5317968B2 (ja) * 2006-07-13 2013-10-16 ガルデルマ・リサーチ・アンド・デヴェロップメント レチノイドと過酸化ベンゾイルとを含む組成物
FR2910321B1 (fr) * 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
WO2008092911A1 (en) * 2007-01-30 2008-08-07 Galderma Research & Development Use of adapalene and benzoyl peroxide for the long term treatment of acne vulgaris
WO2008093346A2 (en) * 2007-02-01 2008-08-07 Sol-Gel Technologies Ltd. Compositions for topical application comprising a peroxide and retinoid
GB0707612D0 (en) 2007-04-19 2007-05-30 Stratosphere Pharma Ab Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
FR2916975B1 (fr) * 2007-06-11 2009-09-04 Galderma Res & Dev Compositions comprenant au moins un compose retinoide, un compose anti-irritant et du peroxyde de benzoyle, et leurs utilisations
KR101538187B1 (ko) * 2007-11-30 2015-07-22 갈데르마 리써어치 앤드 디벨로프먼트 하나 이상의 나프토산 유도체, 과산화 벤조일 및 하나 이상의 필름-형성제를 함유하는 조성물
CA2724804A1 (en) * 2008-05-16 2009-11-19 Galderma Research & Development Therapy regimen for treating acne related diseases
WO2011046609A2 (en) 2009-10-15 2011-04-21 Appleton Papers Inc. Encapsulation
WO2011080741A2 (en) 2009-12-31 2011-07-07 Sol-Gel Technologies Ltd. Core stabilized microcapsules, method of their preparation and uses thereof
MX2012008871A (es) * 2010-02-09 2012-08-31 Galderma Res & Dev Composicion dermatologica que comprende combinacion de adapaleno y peroxido de benzoilo para el tratamiento del acne en poblacion no caucasica con reduccion de hiperpigmentacion post-inflamatoria.
MX363379B (es) * 2011-06-29 2019-03-21 Sol Gel Tech Ltd Formulaciones tópicas estabilizadas que contienen microcápsulas de núcleo-cubierta.
WO2014028608A1 (en) * 2012-08-14 2014-02-20 South Dakota State University Method of treating skin disorders using nanoscale delivery devices and transdermal enhancing compositions
CN105050705B (zh) 2012-09-20 2018-07-27 恩盖普有限公司 喷雾干燥的微胶囊
US9687465B2 (en) 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
EP2938429B1 (en) 2012-12-27 2018-02-28 Encapsys, Llc Microcapsule particles
WO2015092602A1 (en) * 2013-12-17 2015-06-25 Ranbaxy Laboratories Limited Topical pharmaceutical composition of a retinoid
US20160310512A1 (en) * 2013-12-19 2016-10-27 Galderma Research & Development Therapy regimen for treating severe acne related diseases

Also Published As

Publication number Publication date
JP6526322B2 (ja) 2019-06-05
CA2996022A1 (en) 2017-02-23
CA2996022C (en) 2021-01-05
JP2018523693A (ja) 2018-08-23
JP2019142951A (ja) 2019-08-29
EP3337472A4 (en) 2019-05-15
US20180235924A1 (en) 2018-08-23
WO2017029665A1 (en) 2017-02-23
CN108024980A (zh) 2018-05-11
EP3337472A1 (en) 2018-06-27
JP6788066B2 (ja) 2020-11-18

Similar Documents

Publication Publication Date Title
PH12015502659A1 (en) Surface treatment compositions comprising photochromic dyes
MX2017013983A (es) Uso de agentes activos durante tratamientos quimicos.
MX2018005829A (es) Composiciones para tratar el cabello.
MX366262B (es) Composicion que contiene peroxido y agente antimicrobiano y proceso de matar esporas.
CY1117214T1 (el) Συνθεση για ελεγχομενη διεγερση των ωοθηκων
MX2023006706A (es) Administracion transdermica de agentes grandes en composiciones de emulsion mediante acondicionamiento de la piel con microagujas y sus usos.
MX361450B (es) Espuma química sin enjuague que comprende peróxido de benzoilo.
MX2015013177A (es) Combinacion de tratamientod de cancer usando microarns e inhibidores de egfr-tki.
WO2016094834A3 (en) A method for treating a complement mediated disorder caused by an infectious agent in a patient
MA40460A (fr) Ciblage lysosomial et utilisation correspondante
MX2021010886A (es) Uso de medicamentos para disminuir la evolucion de la enfermedad de parkinson.
CL2015001275A1 (es) Composición gel de lavado a base de bpo.
GB2568181A (en) Wheat
MX2017010883A (es) Composicion para el tratamiento de la infertilidad.
MX2017006147A (es) Composiciones y metodos para limpieza personal.
IL271728A (en) Materials, uses and treatment methods
EP3702470A3 (en) Reduction of er-mam-localized app-c99 and methods of treating alzheimer's disease
MX2018002176A (es) Composiciones para aplicaciones topicas que comprenden peroxido de benzoilo y adapaleno.
PH12017501022B1 (en) Compositions comprising 15-hepe and methods of treating or preventing fibrosis using same
MX368268B (es) Formulacion de atazanavir y cobicistat para el tratamiento del virus de inmunodeficiencia humana (vih).
MX2018000379A (es) Material no tejido tratado que tiene una afinidad por un ingrediente activo.
MX2017005793A (es) Metodos y composiciones para una trombolisis segura y efectiva.
PH12016501448B1 (en) Antifungal composition
GB2543709A (en) Pharmaceutical agent
EP3723748A4 (en) ASSOCIATION INCLUDING ADAPALENE, BENZOYL PEROXIDE AND A HEALING GROUP AGENT